Back
Amicus Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
63
FOLD
Amicus Therapeutics, Inc.
Last Price:
$14.36
Seasonality Move:
-5.3%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FOLD is experiencing slight selling pressure.
Amicus Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.34 | Sell |
| 20-day SMA: | 14.31 | Buy |
| 50-day SMA: | 14.02 | Buy |
| 200-day SMA: | 9.17 | Buy |
| 8-day EMA: | 14.34 | Sell |
| 20-day EMA: | 14.28 | Buy |
| 50-day EMA: | 13.54 | Buy |
| 200-day EMA: | 10.62 | Buy |
Amicus Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.14 | Buy |
| Relative Strength Index (14 RSI): | 71.91 | Buy |
| Chaikin Money Flow: | -1847787 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.28 - 14.34) | Buy |
| Bollinger Bands (100): | (8.97 - 14.15) | Buy |
Amicus Therapeutics, Inc. Technical Analysis
| Feb 12 | Feb 13 | Feb 17 | Feb 18 | Feb 19 | Feb 20 | Feb 23 | Feb 24 | Feb 25 | Feb 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 12 | 13 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Amicus Therapeutics, Inc. Stock
Is Amicus Therapeutics, Inc. Stock a Buy?
-
Amicus Therapeutics, Inc. share price is 14.33 while FOLD 8-day simple moving average is 14.34, which is a Sell signal.
-
The stock price of FOLD is 14.33 while Amicus Therapeutics, Inc. 20-day SMA is 14.31, which makes it a Buy.
-
Amicus Therapeutics, Inc. 50-day simple moving average is 14.02 while FOLD share price is 14.33, making it a Buy technically.
-
FOLD stock price is 14.33 and Amicus Therapeutics, Inc. 200-day simple moving average is 9.17, creating a Buy signal.
FOLD Technical Analysis vs Fundamental Analysis
Buy
63
Amicus Therapeutics, Inc. (FOLD)
is a Buy
Is Amicus Therapeutics, Inc. a Buy or a Sell?
-
Amicus Therapeutics, Inc. stock is rated a BuyThe current Amicus Therapeutics, Inc. [FOLD] share price is $14.33. The Score for FOLD is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
Amicus Therapeutics, Inc. Stock Info
Market Cap:
4.5B
Price in USD:
14.33
Share Volume:
5.5M
Amicus Therapeutics, Inc. 52-Week Range
52-Week High:
14.38
52-Week Low:
5.51
Buy
63
Amicus Therapeutics, Inc. (FOLD)
is a Buy
Amicus Therapeutics, Inc. Share Price Forecast
-
What is the Amicus Therapeutics, Inc. stock price today?The Amicus Therapeutics, Inc. stock price is 14.33 USD today.
-
Will FOLD stock go up or go down?Amicus Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Amicus Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Amicus Therapeutics, Inc. is not overvalued.
Is Amicus Therapeutics, Inc. Stock a Buy?
-
Amicus Therapeutics, Inc. share price is 14.33 while FOLD 8-day exponential moving average is 14.34, which is a Sell signal.
-
The stock price of FOLD is 14.33 while Amicus Therapeutics, Inc. 20-day EMA is 14.28, which makes it a Buy.
-
Amicus Therapeutics, Inc. 50-day exponential moving average is 13.54 while FOLD share price is 14.33, making it a Buy technically.
-
FOLD stock price is 14.33 and Amicus Therapeutics, Inc. 200-day simple moving average is 10.62, creating a Buy signal.
Fundamental Analysis of Amicus Therapeutics, Inc.
Is Amicus Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.02 per share, an increase this year of $0.25 per share, and an increase next year of $0.27 per share.
Technical Analysis of Amicus Therapeutics, Inc.
Should I short Amicus Therapeutics, Inc. stock?
-
FOLD Moving Average Covergence Divergence (MACD) indicator is 0.14, suggesting Amicus Therapeutics, Inc. is a Buy
-
Amicus Therapeutics, Inc. Relative Strength Index (RSI) is 71.91, which suggest Amicus Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Amicus Therapeutics, Inc. is (14.28 - 14.34), which suggest Amicus Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Amicus Therapeutics, Inc. is (8.97 - 14.15), which suggest Amicus Therapeutics, Inc. is a Buy
* Amicus Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.